Sarepta Therapeutics (SRPT) Posts Smaller Q3 Loss, Sees Submitting Eteplirsen NDA in Mid-2015

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. NVDA
4. TSLA
5. AMD
6. USO
7. META
8. AMC
9. PSKY
10. NUAI

Go back to Sarepta Therapeutics (SRPT) Posts Smaller Q3 Loss, Sees Submitting Eteplirsen NDA in Mid-2015
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 20.01 -0.1 (0.5%)
Previous Close $20.11    52 Week High $63.73 
Open $20.29    52 Week Low $8.00 
Day High $20.50    P/E N/A 
Day Low $19.97    EPS $-5.69 
Volume 518,985